Whole-Body Gene Mapping: New Tool Creates ‘Virtual Mouse’ for Disease Research

The relentless march of biomedical innovation continues and a recent breakthrough from the University of Chicago’s Pritzker School of Molecular Engineering is poised to reshape how we understand disease at a systemic level. Although advancements in gene expression analysis have been transformative, they’ve often been limited to studying individual organs or small tissue samples. Now, a new system developed by Assoc. Prof. Nicolas Chevrier and his team offers a comprehensive map of gene expression across the entire body – a feat with profound implications for both basic research and the development of new therapies. For residents of Chicago, and particularly those connected to the city’s thriving medical research community, this represents a significant leap forward in our understanding of health and disease.

Mapping the Molecular Landscape of the Mouse

The core of this innovation lies in a novel technique for preparing specimens for examination, coupled with sophisticated computational tools, including a machine learning model. This allows researchers to map gene expression across whole mouse body sections with unprecedented detail. The system accurately identifies all major organs, tissue regions, and approximately 75% of all known cell types within the mouse, creating a powerful toolkit for studying molecular and cellular processes throughout the organism. The findings, published in Cell, aren’t just an academic exercise; they offer a foundation for building what Chevrier describes as a “virtual mouse” – a computational model capable of testing therapies and predicting body-wide biological responses.

This isn’t simply about cataloging genes; it’s about understanding how they interact and respond to stimuli across the entire body. As Chevrier explains, “We now have a tool to generate datasets at a scale that was previously unimaginable. It lays a foundation to generate the kind of data which you’d necessitate to build a ‘virtual mouse’ that could be used to test therapies and understand body-wide biological processes. That’s the ultimate goal.” This ambition aligns with the broader goals of institutions like the University of Chicago Medical Center, which consistently ranks among the nation’s leading hospitals and research facilities.

Array-seq and the Challenge of Whole-Body Analysis

The team’s breakthrough builds upon a technique called spatial transcriptomics, which combines high-resolution microscopy with genetic sequencing to measure gene expression within tissues. While powerful, spatial transcriptomics has traditionally been limited by the small scale of analysis. Chevrier’s team sought to overcome this limitation by developing Array-seq in 2025, a method utilizing DNA microarrays with custom-designed probes to analyze tissue samples. However, applying Array-seq to an entire mouse body presented a significant challenge: creating extremely thin slices of frozen tissue, transferring them onto Array-seq slides while preserving RNA integrity.

Collaboration proved crucial. Working with Prof. Tadafumi Kawamoto of Tsurumi University in Yokohama, Japan, the team successfully created cross-sections of whole mouse bodies just the thickness of a single cell. This delicate process, combined with the development of a new computational model – a collaboration with Ashwini Patil of Combinatics in Chiba, Japan – allowed them to annotate the cellular information of the entire mouse. Further enhancing the system, they partnered with AI expert Prof. Feng Bao of Fudan University in Shanghai, China, to create a machine learning model capable of identifying organs, tissues, and cell types in standard hematoxylin and eosin-stained tissue sections. This eliminates the need for laborious manual labeling with antibodies, significantly reducing cost and complexity.

“If you were to do this manually, you would need to label all these different cell types with staining reagents such as antibodies in the lab, and it is currently infeasible to do across the mouse body,” Chevrier said. “We trained an AI model to do this, so now we can do it virtually and extremely cheaply.” This reliance on artificial intelligence reflects a growing trend in biomedical research, with institutions like the Argonne National Laboratory, located just outside of Chicago, playing a leading role in developing advanced AI algorithms for scientific applications.

Systemic Inflammation and the Sepsis Model

To demonstrate the capabilities of their new system, the researchers applied it to study systemic inflammation in a mouse model of sepsis – a life-threatening condition caused by a dysregulated immune response to infection. For the first time, they were able to quantify the impact of inflammation on every cell type and major organ tissue at an unprecedented scale. This detailed mapping provides a deeper understanding of how sepsis affects the body, potentially leading to the development of more effective treatments. The implications extend beyond sepsis, offering a powerful tool for studying other inflammatory diseases, such as autoimmune disorders and chronic infections.

Toward a ‘Virtual Mouse’ and the Future of Drug Discovery

The potential applications of this technology are vast. It can be used to study how genes influence processes across the entire body, or to assess the effects of new drugs on various tissues and organs. “It can show how drugs are impacting tissues in ways that weren’t predicted,” Chevrier noted. The ultimate goal, however, is to create a comprehensive model of the mouse body – a “virtual mouse” – that can be used to simulate biological processes and test therapies without the need for animal experimentation. This aligns with the growing emphasis on the “3Rs” of animal research: Replacement, Reduction, and Refinement.

The next step involves extending the system to model the entire three-dimensional structure of the mouse body, rather than just single slices. This will require further advancements in imaging and computational modeling, but the team is confident that it is achievable. The data generated by this system could revolutionize drug discovery, allowing researchers to identify promising candidates more quickly and efficiently. Given the concentration of pharmaceutical companies and biotech startups in the greater Chicago area, this technology could have a significant economic impact, fostering innovation and creating new jobs.

Navigating the Implications for Chicago Residents

Given my background in molecular biology and a deep understanding of the evolving landscape of biomedical research, if this trend impacts you or a loved one in the Chicago area, here are three types of local professionals you should consider consulting:

Genomic Medicine Specialists

Look for physicians with board certification in clinical genetics or genomic medicine. They can help interpret the implications of gene expression data for your individual health and guide you toward personalized treatment options. Experience with spatial transcriptomics data is a plus.

Bioinformatics Consultants

If you’re involved in research or drug development, a bioinformatics consultant can help you analyze and interpret complex genomic datasets. Seek consultants with expertise in machine learning and statistical modeling, and a proven track record of working with spatial transcriptomics data.

Medical Ethicists

As genomic medicine becomes more prevalent, ethical considerations grow increasingly vital. A medical ethicist can provide guidance on issues such as data privacy, informed consent, and the responsible use of genomic information. Look for ethicists affiliated with reputable hospitals or universities in the Chicago area.

Ready to find trusted professionals? Browse our complete directory of top-rated healthcare professionals in the Chicago area today.